Wei Xu

Prof. Wei Xu


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2011 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
CFCheng Fang
Cheng Fang
DZDan-Xia Zhu
Dan-Xia Zhu
HDHua-Jie Dong
Hua-Jie Dong
ZZZhi-Jian Zhou
Zhi-Jian Zhou
YWYin-Hua Wang
Yin-Hua Wang
JLJian-Yong Li
Jian-Yong Li

23 July 2015 in Scientific Reports
Verified
Journal Article
Open access
TLTing-Xun Lu
Ting-Xun Lu
JLJin-Hua Liang
Jin-Hua Liang
YMYi Miao
Yi Miao
LFLei Fan
Lei Fan
LWLi Wang
Li Wang
JLJian-Yong Li
Jian-Yong Li
Epstein-Barr virus (EBV) positive diffuse large B-cell lymphoma (DLBCL) of the elderly is defined as patients older than 50 years alone. However, recent studies showed young patients with sound immune status could also be affected. In this study, we investigated the clinical features and outcomes of patients with EBV positive DLBCL in the different age groups using different EBER cut-off values. The prevalence of EBV positive DLBCL was 14.0% (35/250) and 10.4% (26/250) for EBER cut-off of 20% and 50%, respectively. With both EBER cut-off values, patients with EBV DLBCL shared many unfavorable prognostic characteristics, regardless of age. EBV positive patients, both in the elderly and young groups, showed significantly worse overall survival and progression-free survival than negative cases. Moreover, no significant differences of outcomes were identified between different age groups with EBV positive DLBCL. In conclusion, EBV positive DLBCL patients, regardless of age, shared similar poor prognostic features and showed worse outcome than negative cases. We suggest that the age criterion of EBV positive DLBCL of the elderly and possibly the name itself, be modified in future.

7 March 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YMYi Miao
Yi Miao
HZHua-Yuan Zhu
Hua-Yuan Zhu
CQChun Qiao
Chun Qiao
YXYi Xia
Yi Xia
YKYiling Kong
Yiling Kong
JLJian-Yong Li
Jian-Yong Li
Hemophagocytic lymphohistiocytosis (HLH) can be classified into primary HLH and secondary HLH. Primary HLH usually occurs in infants and children with an underlying genetic defect, and there are also teens and occasional adults with primary HLH. Most cases with secondary HLH are adult patients with secondary triggers including infections, malignancies, and autoimmune diseases. The distinction between primary HLH and secondary HLH seems to be less straightforward, as patients with secondary HLH may also have genetic defects while primary HLH can be triggered by secondary causes. In this study, using amplicon-based targeted gene sequencing (TGS), we sequenced eighteen HLH-related genes in 112 adult HLH cases, which were mostly secondary HLH. Mutations or rare variants were identified in 48 cases (42.9%). All the variants except one were missense variants, and biallelic gene mutations were identified in 3 cases in which only one case harbored homogenous missense mutation. Recurrent variants including UNC13D p.G863D and AP3B1 p.T359A are much more prevalent in our cohort than in normal East Asian population, and in silico analysis predicted pathogenicity of these variants. In conclusion, according to our study, genetic defects may also contribute to the development of adult HLH cases or secondary HLH cases.

9 May 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
RGRui Gao
Rui Gao
JLJin‐Hua Liang
Jin‐Hua Liang
LWLi Wang
Li Wang
HZHua‐Yuan Zhu
Hua‐Yuan Zhu
WWWei Wu
Wei Wu
WXWei Xu
Wei Xu

14 October 2019 in Leukemia
Verified
Journal Article
Closed access
PDF file
ZWZijuan Wu
Zijuan Wu
HSHandong Sun
Handong Sun
WLWenjie Liu
Wenjie Liu
HZHuayuan Zhu
Huayuan Zhu
JFJianxin Fu
Jianxin Fu
HJHui Jin
Hui Jin

1 August 2014 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
SYShu Yang
Shu Yang
JLJian-Yong Li
Jian-Yong Li
WXWei Xu
Wei Xu